Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes, and other hematologic malignancies and also therapies for Oncology. Geron Co. (NASDAQ:GERN) released its quarterly earnings data on Thursday, May, 28th. The biopharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.04. StockTwits Read live tweets from the financial and investing community about the stock you're interested in. Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health. Researching Ocugen (NASDAQ:OCGN) stock? View OCGN's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat.
3 Risks Amarin Still Faces After Its Huge FDA Win for Vascepa The drugmaker just won its biggest victory yet. But it's not totally out of the woods. Find real-time IDXG - Interpace Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. The 8 Best Apps for Hardcore Stock Traders Those penny shares aren't going to pick themselves. Use these financial tools to stay informed—and ready to move—at all times. Find tomorrow's biggest winners before they happen! Our proprietary algorithms scan thousands of stocks each day to find the ones with the greatest chance of making big moves. It makes investing so much easier and much more profitable.
APTO Conversations From StockTwits - StockNews Featured Post From StockTwits About APTO $APTO Guys trust me what I am telling you, the short term bias is to the down side you can see it clearly in the daily and 60 Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Individual Stock Analysis on tickers submitted by you on Stocktwits and Twitter. Stocks featured in this video: GIII APTO GDX NEM PYPL COST APO Subscribe t Aptose Biosciences Inc. (NASDAQ: APTO) stock closed at 7.74 per share at the end of the most recent trading day (a -0.77 % change compared to the prior day closing price) with a volume of 625.29K shares and market capitalization of 590.25M.Is a component of indexes and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 24 people. The Company's APTO-253 is a small molecule that can induce expression of the genes that codes for the Kruppel-like factor 4 (KLF4) master transcription factor and the p21 cell cycle inhibitor protein. Biotechnology Cancer Biology Chemotherapy Cancer Research PALM BEACH, Florida, Dec. 10, 2019 /PRNewswire/ -- Much R&D from companies and investors has been pouring into the targeted drug therapies markets, enabling pharma companies and other industry
April 9, 2020 iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute - The Nonprofit Will Help Lead Pre-Clinical Development and Clinical Trial Oversight - NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) ("iBio" or the "Company"), a biologics contract manufacturing organization and **05/14 REPORTS SPCB (T/$5) Jan. 8th crypto services, allows users to load funds into their SuperWallet mobile application through a credit card and bank account or by providing cash at any supporting top-up location or agent. SuperPay's Bitcoin and cryptocurrency capabilities in development will allow users also without a bank account or credit card to load and receive funds and then use Immune Design Corp is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.